IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management I, LLC

Q4 2013 Holdings

Filed 2014-02-14 | 9 holdings | $102.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karyopharm Therapeutics Inc.(KPTIEUR)COM48576U106$32.6K1,585,74331.7%
Ambit Biosciences CorporationCOM02318X100$20.0K2,079,56919.5%
Keryx Biopharmaceuticals Inc.COM492515101$17.0K1,312,00616.5%
Acelrx Pharmaceuticals, Inc.(ACRXUSD)COM00444T100$15.6K1,379,08015.2%
Xencor, Inc.(XNCR)COM98401F105$7.5K820,0007.3%
Novavax Inc.COM670002104$6.8K1,336,2006.6%
Acceleron Pharma Inc.(XLRN)COM00434H108$2.6K66,0002.5%
BioDelivery Sciences International, Inc.(BDSIUSD)CallCOM09060J106$7202,0000.7%
Novavax Inc.PutCOM670002104$166,5080.0%